Fluorouracil (5-FU) is a common antimetabolite chemotherapy drug used to treat a host of cancers. As a pyrimidine analog, 5-FU ruins nucleic acid synthesis, preventing DNA and RNA production. This feature is what makes it so efficient against rapidly multiplying cancer cells. It is now available in systemic and topical forms with a potential spectrum of applications stretching from advanced cancers to skin.
Catalog | Name | Inquiry |
OFC51218 | 5-Fluorouracil | Inquiry |
The therapeutic efficacy of 5-FU lies in its metabolic activation and subsequent enzyme inhibition. After it is delivered, 5-FU is metabolised in the body into active molecules including 5-fluoro-2'-deoxyuridine monophosphate (FdUMP). FdUMP forms a covalent ternary complex irreversibly with TS, a DNA-sparing enzyme, and a folate cofactor. This interactions shuts down TS and causes thymidine depletion, DNA oxidation and failure of replication. In the meantime, 5-FU metabolites disrupt RNA processing and activity to further suppress tumor growth and induce cancer cell death.
Colorectal Cancer
Fluorouracil is the gold standard in colorectal cancer treatment. It's often used in combination programs – for example:
a) FOLFOX: 5-FU with oxaliplatin and leucovorin, enhancing efficacy in adjuvant and metastatic settings.
b) FOLFIRI: A combination with irinotecan, particularly effective for metastatic colorectal cancer.
These regimens improve survival rates, tumor shrinkage, and patient quality of life.
Breast and Gastric Cancers
In breast cancer, 5-FU is used in combination chemotherapy regimens to boost its anti-tumor effect. Also, in gastric cancer, 5-FU regimens are adjuvant or neoadjuvant treatments, lowering recurrence and distant metastasis.
Other Applications
Fig.1 Various key enzymes facilitate the mechanism of action (anabolism) of 5-FU in cancer cells and its elimination (catabolism) via the hepatic system[1].
Efficacy of fluorouracil has been known to have several side effects, requiring careful management.
A. Gastrointestinal Toxicity
Nausea, vomiting, diarrhea, and mucositis are some symptoms that can be treated by antiemetics (e.g., ondansetron or granisetron) and pharmacological adjustment.
B. Hematologic Toxicity
Stemming up of the bone marrow can cause leukopenia, thrombocytopenia, and anemia. Monitoring of blood count is a necessity. Growth factors like G-CSF (granulocyte colony-stimulating factor) help lessen leukopenia.
C. Dermatological and Neurological Effects
D. Special Populations
Fluorouracil is still a gold standard in oncology because of its general effectiveness and various routes of administration. Properly administered and supported, the therapeutic value of fluorouracil outweighs its risks. Alfa Chemistry provides high-purity fluorouracil for research and drug development, which can be derived with assurance of optimal quality and results to help revolutionize cancer therapy. This dedication underlines its status as a reliable partner in science.
Catalog | Name | Inquiry |
OFC522654100 | 6-Ethoxy-5-fluorouracil | Inquiry |
OFC128887354 | 5-Fluoro-1-((3-nitro-4-propoxyphenyl)sulfonyl)pyrimidine-2,4(1H,3H)-dione | Inquiry |
OFC1480962-3 | 5-Fluoro-2-methoxy-4-pyrimidinone | Inquiry |
OFC155168 | 5-Fluoro-1-methylpyrimidine-2,4(1H,3H)-dione | Inquiry |
OFC1866248465 | 5-Fluoro-2-methoxypyrimidin-4-ol | Inquiry |
OFC220141708 | 5-Fluoroorotic Acid Monohydrate | Inquiry |
OFC4840691 | 5-Fluoro-3-methylpyrimidine-2,4(1H,3H)-dione | Inquiry |
OFC4871141 | 1-Allyl-5-fluoropyrimidine-2,4(1H,3H)-dione | Inquiry |
OFC56058992 | 5-Fluoro-1-propionylpyrimidine-2,4(1H,3H)-dione | Inquiry |
OFC56177801 | 2-Ethoxy-5-fluoropyrimidin-4(3H)-one | Inquiry |
OFC61251772 | 3-Benzoyl-5-fluoropyrimidine-2,4(1H,3H)-dione | Inquiry |
OFC61251783 | 5-Fluoro-3-(4-nitrobenzoyl)pyrimidine-2,4(1H,3H)-dione | Inquiry |
Reference
Please kindly note that our products and services are for research use only.